1. Home
  2. BFRI vs GOVX Comparison

BFRI vs GOVX Comparison

Compare BFRI & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFRI
  • GOVX
  • Stock Information
  • Founded
  • BFRI 1997
  • GOVX 2001
  • Country
  • BFRI United States
  • GOVX United States
  • Employees
  • BFRI N/A
  • GOVX N/A
  • Industry
  • BFRI Biotechnology: Pharmaceutical Preparations
  • GOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFRI Health Care
  • GOVX Health Care
  • Exchange
  • BFRI Nasdaq
  • GOVX Nasdaq
  • Market Cap
  • BFRI 7.9M
  • GOVX 7.6M
  • IPO Year
  • BFRI 2021
  • GOVX N/A
  • Fundamental
  • Price
  • BFRI $0.93
  • GOVX $0.70
  • Analyst Decision
  • BFRI Strong Buy
  • GOVX Strong Buy
  • Analyst Count
  • BFRI 1
  • GOVX 4
  • Target Price
  • BFRI $2.75
  • GOVX $10.50
  • AVG Volume (30 Days)
  • BFRI 82.9K
  • GOVX 1.3M
  • Earning Date
  • BFRI 08-13-2025
  • GOVX 07-28-2025
  • Dividend Yield
  • BFRI N/A
  • GOVX N/A
  • EPS Growth
  • BFRI N/A
  • GOVX N/A
  • EPS
  • BFRI N/A
  • GOVX N/A
  • Revenue
  • BFRI $37,997,000.00
  • GOVX $6,143,044.00
  • Revenue This Year
  • BFRI $11.75
  • GOVX N/A
  • Revenue Next Year
  • BFRI $17.09
  • GOVX N/A
  • P/E Ratio
  • BFRI N/A
  • GOVX N/A
  • Revenue Growth
  • BFRI 14.28
  • GOVX 1943.07
  • 52 Week Low
  • BFRI $0.54
  • GOVX $0.43
  • 52 Week High
  • BFRI $2.22
  • GOVX $11.18
  • Technical
  • Relative Strength Index (RSI)
  • BFRI 50.53
  • GOVX 44.62
  • Support Level
  • BFRI $0.88
  • GOVX $0.66
  • Resistance Level
  • BFRI $0.96
  • GOVX $0.70
  • Average True Range (ATR)
  • BFRI 0.09
  • GOVX 0.06
  • MACD
  • BFRI -0.02
  • GOVX -0.00
  • Stochastic Oscillator
  • BFRI 16.67
  • GOVX 20.96

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: